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Abstract
Background: High quality hospital discharge communications about acute kidney injury (AKI) could facilitate
continuity of care after hospital transitions and reduce patients’ post-hospitalization health risks.
Methods: We characterized the presence and quality (10 elements) of written hospital discharge communications
(physician discharge summaries and patient instructions) for patients hospitalized with AKI at a single institution in
2012 through medical record review.
Results: In 75 randomly selected hospitalized patients with AKI, fewer than half of physician discharge summaries
and patient instructions documented the presence (n = 33, 44 % and n = 10, 13 %, respectively), cause (n = 32, 43 %
and n = 1, 1 %, respectively), or course of AKI (n = 23, 31 %, discharge summary only) during hospitalization. Few
provided recommendations for treatment and/or observation specific to AKI (n = 11, 15 and 6, 8 % respectively). In
multivariable analyses, discharge communications containing information about AKI were most prevalent among
patients with AKI Stage 3, followed by patients with Stage 2 and Stage 1 (adjusted percentages (AP) [95 % CI]: 84 %
[39–98 %], 43 % [11–82 %], and 24 % [reference], respectively; p trend = 0.008). AKI discharge communications were
also more prevalent among patients with known chronic kidney disease (CKD) versus those without (AP [95 % CI]:
92 % [51–99 %] versus 39 % [reference], respectively, p = 0.02) and among patients discharged from medical versus
surgical services (AP [95 % CI]: 73 % [33–93 %] versus 23 % [reference], respectively, p = 0.01). Communications
featured 4 median quality elements. Quality elements were greater in communications for patients with more
severe AKI (Stage 3 (number of additional quality elements (β) [95 % CI]: 2.29 [0.87–3.72]), Stage 2 (β [95 % CI]: 0.62
[−0.65–1.90]) and Stage 1 (reference); p for trend = 0.002).
Conclusions: Few hospital discharge communications in AKI patients described AKI or provided recommendations
for AKI care. Improvements in the quality of hospital discharge communications to improve care transitions of
patients with AKI are needed.
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Background
Acute kidney injury (AKI) is increasingly common
among hospitalized patients [1–4] and is associated with
an increased risk of patients’ subsequent chronic kidney
disease (CKD) incidence or progression to end stage
renal disease as well as increased risks of in-hospital and
long-term mortality [5–8]. Hospitalizations in which
AKI occur often require medication adjustments and
specialty care which can influence patients’ transition
from inpatient to ambulatory care settings as well as
their long-term care [9, 10]. Due to the risks associated
with AKI, Kidney Disease Improving Global Outcomes
(KDIGO) has issued clinical practice guidelines which
recommend close follow-up of patients after an AKI
event to monitor for early evidence of CKD or progres-
sion (i.e., monitoring for proteinuria or reduced esti-
mated glomerular filtration rate) [11].
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Inpatient health care providers’ acknowledgement and
communication to patients’ ambulatory care providers
about the occurrence of AKI during hospitalizations rep-
resents a crucial first step to ensuring patients receive
recommended follow-up and monitoring after hospital
discharge [11]. By communicating with ambulatory care
providers (directly or via discharge summaries) about
the occurrence, cause, course, and recommended follow-
up care of AKI, inpatient providers can help ensure pa-
tients receive adequate follow up and management of
their kidney function. Patient discharge instructions
also help to ensure that patients receive follow up and are
enabled to engage in disease self-management (i.e.,
avoidance of nephrotoxins and adherence to treatment for
concomitant CKD risks).
Evidence suggests that awareness of AKI among health
care providers and patients is generally suboptimal, and
patients’ receipt of recommended follow-up care (includ-
ing monitoring of kidney function) after a hospitalization
with AKI is lacking [2, 12, 13]. Delayed or lack of adequate
follow-up care after a hospitalization with AKI, particu-
larly among patients with severe AKI, has been shown to
contribute to patients’ poorer health outcomes [14]. A
prior study assessed presence of documentation of kidney
dysfunction in hospital discharge summaries to facilitate
continuity of care of this high risk group [15]; however,
the presence of hospital discharge communication about
AKI to facilitate adequate follow-up has not been pre-
viously explored. We studied the presence and quality
of hospital discharge communication about AKI from
inpatient health care providers to patients’ ambulatory
health care providers and to patients among individuals
hospitalized for AKI in a teaching hospital. We also
studied characteristics of hospitalizations associated with
higher quality discharge communications.
Methods
Study overview
We conducted a cross-sectional manual review of in-
patient hospital medical records to assess the pres-
ence and quality of hospital discharge communication
about AKI.
Study population
We examined serum creatinine measures among all
adult patients (≥18 years-old) hospitalized in January,
April, October and December of 2012 at Johns Hopkins
Hospital in Baltimore, Maryland to assess whether pa-
tients experienced an episode of AKI during their hospi-
talizations. Following KDIGO criteria, we defined the
presence of AKI as any increase in serum creatinine of
≥0.3 mg/dl within 48 h or increase in serum creatinine
to ≥ 1.5 times baseline within the prior 7 days [11]. We
further classified AKI severity as Stage 1 (an increase in
serum creatinine of 1.5–1.9 times baseline or a ≥ 0.3 mg/
dl increase), Stage 2 (an increase in serum creatinine of
2.0–2.9 times baseline), or Stage 3 (an increase in serum
creatinine of ≥3.0 times baseline). Because we did not
have access to patients’ pre-hospitalization serum creatin-
ine, we considered patients’ lowest serum creatinine dur-
ing their hospital stay to represent their baseline serum
creatinine value. After we identified and characterized
AKI among all patients, we randomly selected a subset of
25 patients from each of the three AKI stage groups (total
75 patients) for medical record review.
We excluded patients without a serum creatinine dur-
ing hospitalization, patients requiring renal replacement
therapy prior to their hospitalization; or patients who
died during their admission.
Data collection and measures
Each randomly selected patient’s electronic medical rec-
ord underwent independent reviews by two trained re-
search nurse abstractors. The nurses used a standardized
form to abstract patients’: 1) demographics; 2) clinical
characteristics (e.g., presence of CKD) documented in
the discharge summary; 3) serum creatinine values during
the hospitalization; 4) hospital course (e.g., length of stay
or nephrology consultation during the hospitalization) 5)
the presence of patients’ readmission within 30 days of
hospital discharge; and 6) the presence and details (see
below) of documentation of patients’ AKI in discharge
summaries as well as documentation in patients’ discharge
instructions intended to be printed out and given to pa-
tients at hospital discharge (Additional file 1). In the
health system under study, the discharge summary and
the patients’ discharge instructions are prepared by
the admitting health care team. Nurses collected data
using REDCap (Research Electronic Data Capture), a se-
cure, web-based application designed to support data cap-
ture for research studies [16]. For each patient record, we
examined all data entered independently by nurse abstrac-
tors for discrepancies in a manual review. When we iden-
tified differences, the two nurses re-consulted medical
records and adjudicated. An investigator (R.G. or Y.L.) ad-
judicated any unresolved differences. We also assessed
whether patients’AKI was hospital or community acquired
and we assessed the resolution of patients’ AKI episode.
We considered AKI to be resolved prior to discharge if the
final serum creatinine was <0.3 mg/dl above the nadir cre-
atinine during the hospitalization.
Presence of communication about AKI at hospital discharge
We defined communication about AKI at hospital dis-
charge as being present if there was any notation or de-
scription of the AKI event in either (1) the discharge
summaries written by inpatient providers describing the
course of patients’ hospitalizations or (2) patients’ written
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discharge instructions. We used pre-specified terms
(including ‘AKI’, ‘acute renal insufficiency’, or ‘creatinine in-
crease’; see Additional file 1 for a complete list of terms)
to identify communications pertaining to AKI.
Assessment of quality of AKI communications at hospital
discharge
We examined two primary aspects of AKI hospital dis-
charge summaries: (1) whether summaries included
complete descriptions of patients’ AKI course during the
hospitalization, and (2) whether summaries included ap-
propriate care plans (Table 1). To evaluate completeness
of descriptions, we considered whether discharge sum-
maries included information likely to be necessary for
ambulatory care providers to provide adequate patient
follow-up care for AKI including: (1) the occurrence of
AKI; (2) the cause of AKI, and (3) the course of AKI dur-
ing the hospitalization. To evaluate inclusion of appropri-
ate care plans, we considered whether providers included
(1) recommendations for follow-up appointments, (2) care
plans for treatment and/or observation specific to the oc-
currence of AKI, and (3) identification of an ambulatory
health provider to receive the discharge summary via fax,
electronic communication, or mail. We also evaluated the
type of ambulatory care provider (e.g., primary care, neph-
rology, or other specialist) for whom patients were sched-
uled or recommended to see in follow up care.
We examined whether patient discharge instructions
provided patients with the necessary information to
facilitate self-management and follow-up of AKI, including
(1) the occurrence of AKI; (2) the cause of AKI, (3) care
plans for treatment and/or observation, and (4) recom-
mendations for follow-up with ambulatory care providers.
Statistical analysis
We described the presence and quality of AKI hospital dis-
charge communication in the patients’ written discharge
materials and performed bivariate analyses (e.g., chi-square
or t-tests) to assess differences in the presence and quality
of AKI discharge communications according to patient
(e.g., demographics, CKD status, comorbid medical condi-
tions, AKI severity, AKI resolution, community vs. hospital
acquired AKI, length of stay, intensive care unit stay during
hospitalization, receipt of nephrology consultation) and
system-level (e.g., discharging medical service) characteris-
tics. We constructed a multivariable logistic regression
model to assess patient and system level factors independ-
ently associated with the occurrence of AKI discharge
communication in the discharge summary, patient dis-
charge instructions, or both. We constructed a second
multivariable linear regression model to assess whether the
quality of patients’ discharge communications (i.e., the
number of quality elements out of 10 total quality elements
that are present in both the patients’ discharge summary
(n = 6) and patient discharge instructions (n = 4)) varied by
patient and system factors. Nephrology consultation data
was missing for 13 % of patients. We performed subgroup
analyses among patients with nephrology consultation data
using the two multivariable models described above to
evaluate the independent association of nephrology consult-
ation with the occurrence and quality of discharge commu-
nication about AKI. We performed all statistical analyses
using Stata, version 11 (StataCorp, www.stata.com).
Results
Participant selection
Among 11,372 patients who were hospitalized during
the 4-month time period, we excluded those without a
serum creatinine (n = 392), patients requiring chronic
renal replacement therapies prior to their hospitalization
(n = 512); and patients who died during hospitalization
(n = 179). Of the remaining 10,289 patients, we identified
2859 patients with AKI. We stratified patients according
to AKI severity (Stage 1 (n = 2191), Stage 2 (n = 474), or
Stage 3 (n = 194)), and selected a random sample of 25
patients from within each stratum for a manual review
of their medical records.
Participant characteristics
Among the 75 randomly selected patients with AKI, the
mean age on admission was 56 years old. A majority
were female (n = 46, 61 %) and nearly half were African
American (n = 36, 48 %). Over half (n = 44, 59 %) of
Table 1 Elements of AKI discharge communications assessed
(n = 10)






Description of AKI event
1) Documentation of occurrence of AKI X X
2) Identification of the cause of AKI (e.g.,
medication related, sepsis, etc.)
X X
3) Description of the course of AKI during
the hospitalization (e.g., serum creatinine
prior to the start of AKI episode, peak




4) Recommendations and timing of follow-
up appointments or scheduled follow-up
appointments
X X
5) Recommendations for treatment and/or
observation specific to the occurrence of
AKI
X X
6) Identification of an ambulatory health care
provider (e.g., primary care physicians) to
receive the discharge summary via fax,
electronic communication, or mail.
X
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patients had ≥1 medical risk factor for AKI at the time
of admission and the median Charlson comorbidity
index score was 2 (Interquartile range: 1–4). Patients
were hospitalized a median of 9 days and were most fre-
quently discharged from Medicine (n = 34, 45 %)
followed by Surgical (n = 26, 35 %) inpatient services.
Patients were admitted most commonly for infections
(n = 16, 21 %), followed by diseases or disorders related
to the circulatory system (n = 15, 20 %), the respiratory
system (n = 11, 15 %), malignancy (n = 10, 13 %), or the
digestive system (n = 8, 11 %). The majority (n = 46,
61 %) of patients had hospital-acquired compared to
community-acquired AKI. Twenty percent (n = 13) of
patients with AKI had a nephrology consultation during
their hospitalization.
Patient demographics and clinical characteristics were
similar between AKI Stage groups; except for CKD,
which was not present among patients with Stage 3 AKI.
The median length of stay varied by AKI severity with
longer stays among patients with Stage 3 AKI (15 days),
followed by Stage 2 (10 days) and Stage 1 (6 days) AKI.
The occurrence of nephrology consultations during the
hospitalization also varied by AKI severity with greater
occurrence among patients with Stage 3 AKI (n = 9, 43 %),
followed by Stage 2 (n = 3, 15 %) and Stage 1 (n = 1, 4 %)
AKI (Table 2).
Presence and quality of communication about AKI at
hospital discharge
Description of AKI event
Less than half (n = 33, 44 %) of discharge summaries tar-
geted for ambulatory care providers mentioned the pres-
ence of AKI during hospitalization, and few (n = 10,
13 %) patient instructions mentioned the AKI event.
Rates of AKI communication in the discharge summary
or patient instructions were lowest for patients with
Stage 1 AKI (n = 6, 24 % for discharge summaries and
none for patient instructions) and highest for patients
with Stage 3 AKI (n = 16, 64 % for discharge summaries
and n = 8, 35 % for patient instructions) (Fig. 1).
Among the 33 discharge summaries in which inpatient
provider communications about AKI were present,
nearly all (n = 32, 97 %) mentioned the suspected cause
of patients’ AKI event; however a third (n = 11, 33 %)
lacked some description of the course of AKI (e.g., dis-
charge serum creatinine). The suspected cause of AKI
was infrequently mentioned in the patient instructions
(n = 1, 1 %) (Table 3).
Follow-up care plans
The vast majority of patients had follow-up appointment
recommendations documented in the discharge sum-
mary (n = 60, 80 %) or patient instructions (n = 67,
89 %). Nearly half (n = 33, 44 %) had recommendations
for follow-up with their primary care provider, while
fewer had recommendations to follow up with a cardi-
ologist (n = 10, 13 %) or a nephrologist (n = 5, 7 %).
Follow-up appointments were scheduled within 30 days
from discharge for the majority (n = 63, 84 %) of the pa-
tients. Among the 75 patients, a majority (n = 58, 77 %)
of patients had scheduled appointments within 2 weeks,
and nearly half (n = 35, 47 %) had scheduled appoint-
ments within one week. Few patients had documented
recommendations for treatment (e.g., avoidance of
nephrotoxins, discontinuation of medications) and/or
observation (e.g., follow-up lab tests) related to their
AKI in either the discharge summary (n = 11, 15 %) or
patient instructions (n = 6, 8 %). Follow-up care plans
(type of provider and timing of appointment) were
similar in those with resolved versus unresolved AKI;
however, documented recommendations for follow-up
laboratory tests related to AKI in the written discharge
materials were greater among patients whose AKI was
unresolved versus resolved (n = 8, 33 % versus n = 4,
8 %, p = 0.005) prior to discharge. Patients with docu-
mented CKD in the discharge summary were more likely
to have scheduled follow-up with a nephrologist, com-
pared to patients without CKD (n = 5, 45 % versus n = 0,
0 %, respectively, p < 0.001). There were no statistically
significant differences in recommendations for nephrology
follow-up by AKI severity or by resolution of AKI prior to
discharge. Nearly a quarter (n = 17, 23 %) of patients’
discharge summaries did not have a referring provider
identified to receive a copy of the discharge summary.
Among the 75 patients, none included all 10 quality
elements we assessed in the discharge summary and the
patient instructions, 5 (7 %) included 8–9 elements, 23
(31 %) included 5–7 elements, 29 (39 %) included 3–4
elements, and 18 (24 %) included 2 or fewer elements.
The median (interquartile range) number of quality ele-
ments present in the discharge materials was 3 (3–6).
Determinants of the occurrence and quality of AKI
discharge communications
In multivariable analyses, the prevalence of communica-
tion about AKI in inpatient providers’ discharge sum-
maries was greatest among patients with AKI Stage 3,
followed by patients with Stage 2 and Stage 1 AKI
(adjusted percentages (AP) [95 % CI]: 84 % [39–98 %],
43 % [11–82 %], and 24 % [reference], respectively; p
trend = 0.008). The prevalence of communication about
AKI in discharge summaries was also greater among pa-
tients discharged from medical services compared to sur-
gical services (AP [95 % CI]: 73 % [33–93 %] versus 23 %
[reference], p = 0.01) and among patients with CKD com-
pared to those patients without CKD (AP [95 % CI]: 92 %
[51–99 %] versus 39 % [reference], p = 0.02). The number
of quality elements present in the discharge summary and
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discharge instructions was also greater among those
with more severe AKI (AKI Stage 3 (β [95 % CI]: 2.29
[0.87–3.72]), AKI Stage 2 (β [95 % CI]: 0.62 [−0.65–1.90])
and AKI stage 1 (reference); test for trend across all three
stages p = 0.002) (Table 4).
There was no difference in the presence and quality of
documentation between patients with community versus
hospital acquired AKI or by patients’ recovery of kidney
function prior to discharge. While there was a trend
towards lower hospital readmission rates among those
with AKI discharge communication compared to those
without, the difference was not statistically significant
(AP [95 % CI] 15 % [2–59 %] versus 24 % [reference],
p = 0.14).
In separate multivariable analyses among the subgroup
of patients with nephrology consultation data (n = 65),
the prevalence of communication about AKI in dis-
charge summaries and the number of quality elements
Table 2 Patient characteristics (n = 75)
Patient characteristics Total (n = 75) Stage 1 (N = 25) Stage 2 (N = 25) Stage 3 (N = 25) P value
Age, mean years (SD) 56 (19) 62 (18) 53 (21) 52 (18) 0.16
Female, n (%) 46 (61) 14 (56) 14 (56) 18 (72) 0.41
Race, n (%) 0.35
White 36 (48) 12 (48) 11 (44) 13 (52)
Black 36 (48) 13 (52) 13 (52) 10 (40)
Asian 1 (1) 0 (0) 1 (4) 0 (0)
Other 2 (3) 0 (0) 0 (0) 2 (8)
Diabetes, n (%) 16 (21) 5 (20) 6 (24) 5 (20) 0.92
Hypertension, n (%) 33 (44) 14 (56) 11 (44) 8 (32) 0.23
Chronic kidney disease, n (%) 11 (15) 5 (20) 6 (24) 0 (0) 0.04
Coronary artery disease, n (%) 16 (21) 5 (20) 5 (20) 6 (24) 0.92
Congestive heart failure, n (%) 11 (15) 2 (8) 2 (8) 7 (28) 0.07
Charlson comorbidity score, median (IQR) 2 (1–4) 2 (1–5) 2 (2–4) 2 (0–3) 0.25
Length of stay, median days (IQR) 9 (6–16) 6 (4–7) 10 (8–16) 15 (7–35) <0.001
Admission diagnosis categories
Infectious 16 (21) 3 (12) 5 (20) 8 (32) 0.22
Circulatory 15 (20) 7 (28) 5 (20) 3 (12) 0.37
Respiratory 11 (15) 5 (20) 3 (12) 2 (12) 0.65
Malignancy 10 (13) 4 (16) 4 (16) 2 (8) 0.63
Digestive 8 (11) 2 (8) 5 (20) 1 (4) 0.16
Renal 6 (8) 3 (12) 2 (8) 1 (4) 0.58
Endocrine/metabolic 2 (3) 0 (0) 0 (0) 2 (8) 0.13
Other 7 (9) 1 (4) 1 (4) 5 (20) 0.08
Discharge Service, n (%) 0.26
Medical 34 (45) 12 (48) 13 (52) 9 (36)
Surgical 26 (35) 10 (40) 5 (20) 11 (44)
Oncology 13 (17) 2 (8) 7 (28) 4 (16)
Other 2 (3) 1 (4) 0 (0) 1 (4)
ICU stay during hospitalization, n (%) 23 (31) 6 (24) 5 (20) 12 (48) 0.067
Nadir creatinine, mean (SD) (mg/dl)a 1.01 (0.90) 1.28 (1.25) 1.00 (0.81) 0.76 (0.32) 0.12
Discharge creatinine, mean (SD) (mg/dl) 1.39 (1.09) 1.45 (1.30) 1.30 (1.14) 1.42 (0.82) 0.87
Hospital-acquired AKI, n (%) 46 (61) 14 (56) 14 (56) 18 (72) 0.41
Nephrology Consultb, n (%) 13 (20) 1 (4) 3 (15) 9 (43) 0.004
30 day hospital readmission, n (%) 14 (19) 7 (28) 4 (16) 3 (12) 0.32
aNadir serum creatinine – lowest serum creatinine during hospital admission; Abbreviations: ICU- intensive care unit
bAssessed among 65 patients with consult information available in the electronic medical record
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present in the discharge summary was greater among
patients who had a nephrology consultation compared
to those patients who did not obtain a nephrology con-
sultation during their inpatient admission (AP [95 %
CI]: 99 % [71–100 %] versus 33 % [reference], p = 0.01;
(β [95 % CI]: 1.87 [0.41–3.32], p = 0.01, respectively).
Discussion
Our detailed characterization of the presence and quality
of physicians’ discharge communications about AKI dur-
ing patients’ transitions from inpatient to outpatient set-
tings uncovered numerous communication deficiencies.
Communications about AKI during hospital stays were
infrequent in both physicians’ discharge summaries and
in patients’ discharge instructions. Further, they were less
prevalent and/or of lower quality among patients with less
severe AKI, among patients who were discharged from sur-
gical services, among patients without a history of CKD,
and among patients without a nephrology consultation
during their inpatient stay. Most discharge summaries and
patient instructions lacked sufficient detail regarding the
AKI event, and numerous patients had either no identified
provider to receive communications or poor nephrology
follow up.
To our knowledge, this is the first study to characterize
deficiencies in hospital discharge communications to both
providers and patients that could adversely affect patients’
post hospital care. Prior studies have described the sub-
optimal follow-up care (including inadequate monitoring
of kidney function) of patients after a hospitalization with
AKI [2, 13]. However, little attention has been paid to how
hospital providers’ communications facilitate patients’ suc-
cessful transitions to ambulatory care settings. Our find-
ings provide important insights for efforts to identify
strategies to improve care and outcomes among survivors
of AKI [17].
Our findings of lower communication rates about AKI
when AKI was less severe suggest hospital providers may
not recognize less severe AKI. Dissemination of clinical
practice guidelines to enhance hospital providers’ know-
ledge and awareness of AKI could heighten their aware-
ness of AKI and prompt them to include AKI in discharge
communications more frequently. Decision support tools
(such as electronic medical alerts or checklists) have been
shown to improve care transitions [18] and hospital pro-
viders’ recognition of AKI [19–22], and they could also
enhance providers’ focus on AKI in discharge communi-
cations. These tools could be particularly important for
non-medical specialists who may have substantially less









Description of AKI event
1) Documentation of occurrence of AKI 33 (44) 10 (13)
2) Identification of the cause of AKI 32 (43) 1 (1)




1) Recommendations for follow-up appointments
or scheduled follow-up appointments
60 (80) 67 (89)
2) Recommendations for treatment and/or
observation specific to the occurrence of AKI
11 (15) 6 (8)
3) Identification of an ambulatory health care
provider to receive the discharge summary
via fax, electronic communication, or mail.
58 (77)
Fig. 1 Presence of AKI Documentation in the Discharge Summary and Written Patient Instructions
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experience managing AKI. Greater oversight by the con-
sulting nephrology team regarding the provision of infor-
mation about AKI and follow-up recommendations
within the discharge materials may also be beneficial. In
our study, the greater occurrence and higher quality
discharge communication about AKI among patients who
had a nephrology consultation during their hospitalization
suggests that greater involvement of nephrology care
during the admission and in the discharge planning may
improve care transitions for patients with AKI.
Table 4 Predictors of the Occurrence and Quality of AKI in Discharge Communication
Patient
characteristics
Presence of AKI in discharge communication (N = 75) Quality of AKI discharge communication (N = 75)
Adjusted %a (95 % CI) P value βab (95 % CI) Quality elements P value
Age 0.65 0.47
≥ 65 years 42 (14–76) 0.39 (−0.69, 1.47)
< 65 years 50 (Ref) Ref
Sex
Male 50 (22–78) 0.88 −0.38 (−1.34, 0.58) 0.44
Female 48 (Ref) Ref
Race
African American 62 (31–86) 0.11 0.48 (−0.52, 1.48) 0.34
White/Asian/Other 36 (Ref) Ref
Diabetes
Yes 29 (06–71) 0.52 −0.26 (−1.61, 1.08) 0.70
No 42 (Ref) Ref
Congestive heart failure
Yes 59 (17–91) 0.41 0.93 (−0.57, 2.42) 0.22
No 39 (Ref) Ref
Chronic kidney disease
Yes 92 (51–99) 0.02 1.04 (−0.48, 2.56) 0.18
No 39 (Ref) Ref
AKI stage
3 84 (39–98) 0.009* 2.29 (0.87, 3.72) 0.002*
2 43 (11–82) 0.35 0.62 (−0.65, 1.90) 0.33
1 24 (Ref) Ref
Unresolved AKI on discharge
Yes 47 (18–79) 0.51 0.40 (−0.67, 1.48) 0.46
No 35 (Ref) Ref
Discharge service
Medical 73 (33–93) 0.01 0.87 (−0.21, 1.94) 0.11
Surgery 23 (Ref) Ref
Length of stay (days)
High (13+) 49 (10–89) 0.74 −1.36 (−3.00, 0.28) 0.10
Middle (7–12) 50 (15–85) 0.65 −0.27 (−1.56, 1.01) 0.67
Low (1–6) 40 (Ref) Ref
Intensive care unit stay
Yes 49 (13–85) 0.91 0.54 (−0.72, 1.79) 0.40
No 46 (Ref) Ref
*p for trend in adjusted analysis < 0.05
aAdjusted for age, race, sex, diabetes, congestive heart failure, chronic kidney disease, AKI stage, AKI resolution, discharge service, length of stay and intensive
care unit stay
bβ are for the number of quality elements present in both the discharge summary and the patient discharge instructions
Abbreviations: AKI acute kidney injury
Greer et al. BMC Health Services Research  (2016) 16:449 Page 7 of 9
The low rates of nephrology follow-up care at hospital
discharge observed in our study and in prior studies
[23, 24] may be due to hospital providers’ poor under-
standing of the long-term CKD risks associated with AKI
events and/or uncertainty of which patients should be re-
ferred for subsequent nephrology care. Studies providing
evidence on which patients would benefit most from
early nephrology evaluation and management following a
hospitalization with AKI are needed. While we did not ob-
serve a statistically significant association between the
presence of AKI communication and hospital readmission
in this small study, we did observe a trend towards lower
hospital readmission rates among patients with AKI dis-
charge communication compared to those without AKI
discharge communication, suggesting further studies to
understand the potential impact of discharge communica-
tions on this important clinical outcome are warranted.
The rates of identification of an ambulatory provider
to receive the discharge summary observed in our study
was suboptimal, and may in part be due to fragmented
care structures in which ambulatory providers are not
always affiliated directly with the admitting hospital.
Greater integration of health care systems could facilitate
timely discharge communication about AKI to ambulatory
providers and timely follow-up of AKI after hospital dis-
charge. Additionally, implementation of multidisciplinary
discharge planning teams could also aid communication
about AKI during care transitions, particularly if teams are
trained to communicate (both verbally and in writing)
with ambulatory primary care providers and nephrologists
about AKI, to provide patient education about AKI,
to facilitate medication reconciliation, and to schedule
ambulatory follow-up appointments.
The limitations of our study deserve mention. First,
we assessed documentation among a small number of
randomly selected patients receiving care in a single
teaching hospital over one year period, which may po-
tentially limit the generalizability of our results. AKI
communication rates may differ at other hospitals or in
other geographic regions. However, our findings are con-
sistent with other studies demonstrating deficiencies
with AKI recognition and follow-up care [2, 13, 25–27].
New clinical practice guidelines for AKI emerged in 2012
and the cross-sectional design of our study limits our abil-
ity to assess changes in rates of discharge communication
about AKI over time [11]. Longitudinal studies elucidating
time related trends in rates of AKI discharge communica-
tion in relation to release of the new guidelines could help
clarify whether patterns of care are improving as greater
awareness about AKI risks evolve among the general
medical community. Second, we assessed only written
discharge materials. It is possible other types of com-
munication (e.g., telephone or electronic communication
with ambulatory providers or in-person discussions with
patients) occurred at the time of patients’ hospital
discharge. Third, because not all patients received their
outpatient care in the health system under study, we
established the nadir creatinine during the hospital stay as
a reflection of patients’ baseline serum creatinines. It is
possible this approach could have resulted in bidirectional
misclassification of patients’ AKI diagnosis and severity
[28, 29]. Nonetheless, we believe it is common in the US,
where many health systems are not integrated, for clini-
cians to make judgements about the presence of AKI with
limited outpatient data available. Thus, we believe our as-
sessments of AKI and measurement of clinical care in the
presence of AKI are likely to reflect those made in similar
real-world settings. Finally, we were unable to ascertain
whether primary care providers followed up on reported
AKI. Future studies are needed to assess whether im-
proved discharge communication about AKI improves the
provision of appropriate ambulatory follow-up and re-
duces patients’ post-hospitalization health risks.
Conclusions
In summary, communication of AKI events between
hospital providers to patients and their ambulatory pro-
viders during hospital discharge transitions was low and
the overall quality of the documentation was poor. Efforts
to enhance awareness of AKI and to prompt improved
communication at the time of hospital discharge, may im-
prove care transitions for these high risk patients.
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